Reset Mind Sciences

Follow
Get notifications in MyBN when activity occurs. Upgrade your subscription to use this feature.

Reset Mind Sciences was incorporated on 28 May 2021 in Western Australia as a wholly-owned subsidiary of Little Green Pharma, a vertically integrated medicinal cannabis company, to focus specifically on psychedelic medicines.

Reset Mind Sciences has sought to capitalise on Little Green Pharma’s knowledge, track record, infrastructure and regulatory approvals to pursue a business in the field of psychedelic medicines. It plans to continue to leverage this relationship into the future with Reset Mind Sciences to have exclusive access to LGP’s Schedule 9 licenced production facility for psilocybin production.

Reset sees itself as an industry-disruptor at the beginning of a breakthrough in mental health treatment – an entirely new breed of pharma-therapy company. Its vision is to help provide a meaningful new treatment option for mental health through the use of psychedelic medicines.

Contact Details

Company Activity

Reset Mind Sciences, HIF unite for mental health
NEWS: Tagged in Reset Mind Sciences, HIF unite for mental health23 Mar 2023
Reset revives the magic of mycology
NEWS: Tagged in Reset revives the magic of mycology24 Oct 2022
Angus Caithness
NEW ROLE: Angus Caithness, Executive Director24 Oct 2022
Cheryl Edwardes
NEW ROLE: Cheryl Edwardes, Non-Executive Chair24 Oct 2022
Shaun Duffy
NEW ROLE: Shaun Duffy, Chief Executive24 Oct 2022

News Articles

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options